| ■ 영문 제목 : Global 23-valent Pneumococcal Vaccine Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2108K202091 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 135 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 23가 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (단일 투여용 바이알, 프리필드 실린지)와 용도별 시장규모 (만성 심혈관 질환, 만성 폐 질환, 만성 간 질환, HIV 감염자, 백혈병, 림프종, 다발성 골수종, 일반 악성 종양, 만성 신장 질환, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 23가 폐렴구균 백신 시장 점유율 - 지역별 23가 폐렴구균 백신 시장규모 - 주요지역의 종류별 시장규모 (단일 투여용 바이알, 프리필드 실린지) - 주요지역의 용도별 시장규모 (만성 심혈관 질환, 만성 폐 질환, 만성 간 질환, HIV 감염자, 백혈병, 림프종, 다발성 골수종, 일반 악성 종양, 만성 신장 질환, 기타) - 미주의 23가 폐렴구균 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 23가 폐렴구균 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 23가 폐렴구균 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 23가 폐렴구균 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 23가 폐렴구균 백신 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2021 growth of 23-valent Pneumococcal Vaccine will have significant change from previous year. By the most conservative estimates of global 23-valent Pneumococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 23-valent Pneumococcal Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Chronic Cardiovascular Disease
Chronic Lung Disease
Chronic Liver Disease
People Living with Hiv
Leukemia
Lymphoma
Multiple Myeloma
General Malignancy
Chronic Kidney Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
Sanofipasteur
CDIBP
Kexing Bio
Changsheng Bio-Technology
Huaan Science and Technology Innovation
1 Scope of the Report 2 Executive Summary 3 Global 23-valent Pneumococcal Vaccine by Company 4 23-valent Pneumococcal Vaccine by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global 23-valent Pneumococcal Vaccine Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. 23-valent Pneumococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Single Dose Vial Table 3. Major Players of Pre-filled Syringe Table 4. Global 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units) Table 5. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 6. Global 23-valent Pneumococcal Vaccine Revenue by Type (2016-2021) & ($ million) Table 7. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2016-2021) Table 8. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2016-2021) Table 9. Global 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units) Table 10. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Table 11. Global 23-valent Pneumococcal Vaccine Value by Application (2016-2021) Table 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2016-2021) Table 13. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2016-2021) Table 14. Global 23-valent Pneumococcal Vaccine Sales by Company (2019-2021) & (K Units) Table 15. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2019-2021) Table 16. Global 23-valent Pneumococcal Vaccine Revenue by Company (2019-2021) ($ Millions) Table 17. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2019-2021) Table 18. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2019-2021) Table 19. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area Table 20. Players 23-valent Pneumococcal Vaccine Products Offered Table 21. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) (K Units) Table 25. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021) Table 26. Global 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 27. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021) Table 28. Americas 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units) Table 29. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 30. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 32. Americas 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units) Table 33. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 34. Americas 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units) Table 35. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Table 36. APAC 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) & (K Units) Table 37. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021) Table 38. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021) Table 40. APAC 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units) Table 41. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 42. APAC 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units) Table 43. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Table 44. Europe 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units) Table 45. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 46. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 48. Europe 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units) Table 49. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 50. Europe 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units) Table 51. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of 23-valent Pneumococcal Vaccine Table 61. Key Application and Potential Industries of 23-valent Pneumococcal Vaccine Table 62. Key Challenges of 23-valent Pneumococcal Vaccine Table 63. Key Trends of 23-valent Pneumococcal Vaccine Table 64. 23-valent Pneumococcal Vaccine Distributors List Table 65. 23-valent Pneumococcal Vaccine Customer List Table 66. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global 23-valent Pneumococcal Vaccine Consumption Market Forecast by Region Table 68. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2021-2026) Table 80. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2021-2026) Table 82. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2021-2026) Table 84. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2021-2026) Table 86. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 87. Merck 23-valent Pneumococcal Vaccine Product Offered Table 88. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 89. Merck Main Business Table 90. Merck Latest Developments Table 91. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 92. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered Table 93. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 94. Sanofipasteur Main Business Table 95. Sanofipasteur Latest Developments Table 96. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 97. CDIBP 23-valent Pneumococcal Vaccine Product Offered Table 98. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 99. CDIBP Main Business Table 100. CDIBP Latest Developments Table 101. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 102. Kexing Bio 23-valent Pneumococcal Vaccine Product Offered Table 103. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 104. Kexing Bio Main Business Table 105. Kexing Bio Latest Developments Table 106. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 107. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered Table 108. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 109. Changsheng Bio-Technology Main Business Table 110. Changsheng Bio-Technology Latest Developments Table 111. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors Table 112. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered Table 113. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 114. Huaan Science and Technology Innovation Main Business Table 115. Huaan Science and Technology Innovation Latest Developments List of Figures Figure 1. Picture of 23-valent Pneumococcal Vaccine Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2016-2026 (K Units) Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Single Dose Vial Figure 10. Product Picture of Pre-filled Syringe Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2016-2021) Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2016-2021) & (K Units) Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2016-2021) & (K Units) Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2016-2021) & (K Units) Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2016-2021) & (K Units) Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2016-2021) & (K Units) Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2016-2021) & (K Units) Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2016-2021) & (K Units) Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2016-2021) & (K Units) Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2016-2021) & (K Units) Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2016-2021) & (K Units) Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021) Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2020 Figure 35. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2020 ($ Million) Figure 36. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2020 Figure 37. Global 23-valent Pneumococcal Vaccine Sales Market Share by Regions (2016-2021) Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region in 2020 Figure 39. Americas 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units) Figure 40. Americas 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 41. APAC 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units) Figure 42. APAC 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 43. Europe 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units) Figure 44. Europe 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 45. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units) Figure 46. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions) Figure 47. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 48. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 50. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020 Figure 51. United States 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 52. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 53. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 54. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 55. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2020 Figure 56. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2020 Figure 57. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 58. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020 Figure 59. China 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 60. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 61. Korea 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 62. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 63. India 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 64. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 65. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 66. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 67. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 68. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020 Figure 69. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 70. France 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 71. UK 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 72. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 73. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 74. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020 Figure 75. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020 Figure 76. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020 Figure 77. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020 Figure 78. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 79. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 80. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 81. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 82. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 83. Channels of Distribution Figure 84. Distributors Profiles |
| ※본 조사보고서 [세계의 23가 폐렴구균 백신 시장예측 2021년-2026년] (코드 : LPI-2108K202091) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 23가 폐렴구균 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |